Imricor Medical Systems, Inc. (IMR.AX)

AUD 0.96

(-2.05%)

Market Cap (In AUD)

204.66 Million

Revenue (In AUD)

615.56 Thousand

Net Income (In AUD)

-22.62 Million

Avg. Volume

193.11 Thousand

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.41-1.375
PE
-
EPS
-
Beta Value
0.253
ISIN
AU0000054942
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Steven Wedan
Employee Count
-
Website
https://www.imricor.com
Ipo Date
2019-08-30
Details
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.